pharmaceutical investing Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra
medical device investing Arch Therapeutics to Provide Corporate Update at the Maxim Group – Haitong Securities Healthcare Investor and Partnering Conference
Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds
E-Power Resources Inc. Announces Tetepisca Flake Graphite Property Delivers High-Value Concentrate Potential, Demonstrating High Recoveries and Premium Flake Size Distribution
